Design Therapeutics, Inc. Shares (Preferred)

Shares (Preferred) of DSGN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Shares (Preferred) growth rates and interactive chart. Number of preferred shares outstanding in a company.

Highlights and Quick Summary

  • Shares (Preferred) for the quarter ending December 31, 2020 was $22 Million
Visit stockrow.com/DSGN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Shares (Preferred) of Design Therapeutics, Inc.

Most recent Shares (Preferred)of DSGN including historical data for past 10 years.

Interactive Chart of Shares (Preferred) of Design Therapeutics, Inc.

Design Therapeutics, Inc. Shares (Preferred) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $22.01 – – – –

Business Profile of Design Therapeutics, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com